Filing Details

Accession Number:
0001104659-20-019486
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-12 18:40:07
Reporting Period:
2020-02-10
Accepted Time:
2020-02-12 18:40:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1490978 Schrodinger Inc. SDGR () WA
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1166559 Trust Foundation Gates Melinda & Bill 2365 Carillon Point
Kirkland WA 98033
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-10 6,393,429 $0.00 6,393,429 No 4 C Direct
Common Stock Acquisiton 2020-02-10 588,235 $17.00 6,981,664 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B preferred stock Disposition 2020-02-10 29,468,101 $0.00 3,942,041 $0.00
Common Stock Series C preferred stock Disposition 2020-02-10 47,242,235 $0.00 6,319,743 $0.00
Common Stock Series D preferred stock Disposition 2020-02-10 35,946,010 $0.00 4,808,612 $0.00
Common Stock Series E preferred stock Disposition 2020-02-10 33,543,539 $0.00 4,487,226 $0.00
Common Stock Limited common stock Acquisiton 2020-02-10 13,164,193 $0.00 13,164,193 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
13,164,193 No 4 C Direct
Footnotes
  1. Upon closing of the Issuer's initial public offering ("IPO"), all of the Series E preferred stock held by Bill & Melinda Gates Foundation Trust (the "Trust") converted automatically into the Issuer's common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series E preferred stock.
  2. Represents shares acquired pursuant to an Issuer directed allocation in connection with the Issuer's IPO of common stock.
  3. Upon closing of the Issuer's IPO, the Trust voluntarily exchanged all of its Series B preferred stock and Series C preferred stock into the Issuer's limited common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series B preferred stock or Series C preferred stock.
  4. Upon closing of the Issuer's IPO, (i) 14,249,523 shares of Series D preferred stock converted automatically into the Issuer's common stock on a 7.47534-for-1 basis without payment of further consideration and (ii) 21,696,487 shares of Seried D preferred stock were voluntarily exchanged at the discretion of the Trust into the Issuer's limited common stock on a 7.47534-for-1 basis without further consideration. There was no expiration date for the Series D preferred stock.
  5. All shares of the Issuer's limited common stock have no expiration date and may be exchanged at the Trust's election into the Issuer's common stock on a 1-for-1 basis without payment of further consideration.